These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

262 related items for PubMed ID: 17539354

  • 1. [Modern strategy in the treatment of chronic hepatitis B: progress and prospects].
    Isakov VA.
    Eksp Klin Gastroenterol; 2007; (2):107-12. PubMed ID: 17539354
    [No Abstract] [Full Text] [Related]

  • 2. [Chronic hepatitis B].
    Thimme R, Spangenberg HC, Blum HE.
    Dtsch Med Wochenschr; 2008 Jan; 133(4):135-8. PubMed ID: 18197589
    [No Abstract] [Full Text] [Related]

  • 3. Prevention of hepatocellular carcinoma.
    Wands JR.
    N Engl J Med; 2004 Oct 07; 351(15):1567-70. PubMed ID: 15470221
    [No Abstract] [Full Text] [Related]

  • 4. [Therapy of chronic hepatitis B. Tenofovir--first choice in current EASL guidelines].
    MMW Fortschr Med; 2009 May 28; 151(22):38-9. PubMed ID: 19526965
    [No Abstract] [Full Text] [Related]

  • 5. Prevention and surveillance of hepatitis B virus-related hepatocellular carcinoma.
    Liaw YF.
    Semin Liver Dis; 2005 May 28; 25 Suppl 1():40-7. PubMed ID: 16103980
    [Abstract] [Full Text] [Related]

  • 6. Antiviral therapy for chronic hepatitis B: are we doing any good to patients?
    Wong VW, Sung JJ.
    J Antimicrob Chemother; 2009 Aug 28; 64(2):223-6. PubMed ID: 19468026
    [Abstract] [Full Text] [Related]

  • 7. HBV genotype and clinical outcome of chronic hepatitis B: facts and puzzles.
    Tseng TC, Kao JH.
    Gastroenterology; 2008 Apr 28; 134(4):1272-3; author reply 1273. PubMed ID: 18395116
    [No Abstract] [Full Text] [Related]

  • 8. Can antiviral therapy for chronic hepatitis B enhance the progression to hepatocellular carcinoma?
    Warner N, Locarnini S.
    Antivir Ther; 2009 Apr 28; 14(2):139-42. PubMed ID: 19430088
    [No Abstract] [Full Text] [Related]

  • 9. Does treatment with interferon-based therapy improve the natural history of chronic hepatitis B infection?
    Lau GK.
    J Hepatol; 2007 Jan 28; 46(1):6-8. PubMed ID: 17112628
    [No Abstract] [Full Text] [Related]

  • 10. Studying the treatment of chronic hepatitis B viral infection in special populations.
    Gish RG, Locarnini S.
    Methods Mol Med; 2004 Jan 28; 96():465-98. PubMed ID: 14762288
    [No Abstract] [Full Text] [Related]

  • 11. Antiviral therapy of chronic hepatitis B.
    Zoulim F.
    Antiviral Res; 2006 Sep 28; 71(2-3):206-15. PubMed ID: 16716414
    [Abstract] [Full Text] [Related]

  • 12. Closing the Stable Door After the Horse Has Bolted: Should We Be Treating People With Immune-Tolerant Chronic Hepatitis B to Prevent Hepatocellular Carcinoma?
    Howell J, Chan HLY, Feld JJ, Hellard ME, Thompson AJ.
    Gastroenterology; 2020 Jun 28; 158(8):2028-2032. PubMed ID: 32088205
    [No Abstract] [Full Text] [Related]

  • 13. Emerging therapies of hepatitis B and C.
    Chen RY, Desmond PV, Locarnini SA.
    J Gastroenterol Hepatol; 2002 Dec 28; 17 Suppl():S471-81. PubMed ID: 12534781
    [No Abstract] [Full Text] [Related]

  • 14. End points of therapy in chronic hepatitis B.
    Ahmed SN, Ecochard M, Zoulim F.
    Expert Rev Gastroenterol Hepatol; 2010 Feb 28; 4(1):37-49. PubMed ID: 20136588
    [Abstract] [Full Text] [Related]

  • 15. Comparison of interferon and lamivudine treatment in Japanese patients with HBeAg positive chronic hepatitis B.
    Arase Y, Ikeda K, Suzuki F, Suzuki Y, Kobayashi M, Akuta N, Hosaka T, Sezaki H, Yatsuji H, Kawamura Y, Kobayashi M, Kumada H.
    J Med Virol; 2007 Sep 28; 79(9):1286-92. PubMed ID: 17607775
    [Abstract] [Full Text] [Related]

  • 16. Prevention of hepatocellular carcinoma: the holy grail of hepatitis B treatment.
    Sherman M.
    J Hepatol; 2009 May 28; 50(5):854-6. PubMed ID: 19303162
    [No Abstract] [Full Text] [Related]

  • 17. Chronic hepatitis B: who to treat and which choice of treatment?
    Di Marco V, Craxì A.
    Expert Rev Anti Infect Ther; 2009 Apr 28; 7(3):281-91. PubMed ID: 19344242
    [Abstract] [Full Text] [Related]

  • 18. [Strategies for the prevention of hepatocellular carcinoma in the context of chronic viral hepatitis].
    Schott E, Bergk A, Berg T.
    Z Gastroenterol; 2008 Jan 28; 46(1):69-80. PubMed ID: 18188819
    [Abstract] [Full Text] [Related]

  • 19. Antiviral therapy of chronic hepatitis B: prevention of drug resistance.
    Fournier C, Zoulim F.
    Clin Liver Dis; 2007 Nov 28; 11(4):869-92, ix. PubMed ID: 17981233
    [Abstract] [Full Text] [Related]

  • 20. Immune responses in hepatitis B virus infection.
    Rehermann B.
    Semin Liver Dis; 2003 Feb 28; 23(1):21-38. PubMed ID: 12616448
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 14.